Biotech SF: Morningside Ventures

Showing posts with label Morningside Ventures. Show all posts

Thursday, November 1, 2012

Advanced Cell Diagnostics lines up $12M Series B round

Diagnostic test developer Advanced Cell Diagnostics Inc. completed a $12 million Series B financing, led by New Leaf Venture Partners.

The Hayward company, which developed its RNAscope technology to detect and quantify RNA biomarkers, said existing investor Morningside Ventures also participated in the round.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.